Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

Jaime Merchan, MD, discusses the background and findings from the LITESPARK-013 trial of belzutifan for the treatment of patients with advanced clear cell renal cell carcinoma.

From repairing deadly brain bleeds to tackling tumors with precise chemotherapy, micro/nano-robots (MNRs) are a promising, up ...

An electronic letter, or nudge, highlighting the cardiovascular benefits of influenza vaccines improved vaccination rates among more than 2 million adults—with a greater impact on those who have had a ...

Endowed Professor and Director of the MSM Cardiovascular Research Institute will be honored during upcoming AHA Scientific ...

In a discussion with the Cobb Institute, Dr. Priscilla Pemu and Tesheia Harris shared insights on how to make clinical trials more inclusive.

In the last few decades, the biomedical research establishment has flipped from an academically-based enterprise to a ...

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

A novel test enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient. This simple and innovative test provides ...